LAC Med Bhd is projected to register 20%, 21%, and 13% earnings growth for financial years (FY25) to FY27 with a three-year compounded annual growth rate of 18.2%.
TheStar20 Feb, 2026 00:00am - 2 weeks
KUALA LUMPUR: RHB Research has initiated coverage on LAC Med Bhd with a “Buy” recommendation, citing expectations that the company will benefit from Malaysia’s healthcare expansion.